Marest Capital »

Werewolf Therapeutics shares owned by Marest Capital

Quarter-by-quarter ownership of Werewolf Therapeutics (HOWL) shares owned by Marest Capital from 13F filings

Historical chart of Marest Capital investment in Werewolf Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Werewolf Therapeutics held by Marest Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Werewolf Therapeutics by Marest Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.9k 11k 0.36

More positions owned by Marest Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr 0-3 Mth Treasury (SGOV)
Blackrock Etf Trust Ii Isha Flex In Etf (BINC)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Goldman Sachs (GS)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Wal-Mart Stores (WMT)
Madison Square Grdn Sprt Cor Cl A (MSGS)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
American Express Company (AXP)
Cisco Systems (CSCO)

View all positions for Marest Capital

Top funds holding Werewolf Therapeutics

RA Capital Management
Balyasny Asset Management
Vanguard Capital Management
Renaissance Technologies
Lynx1 Capital Management
Sphera Funds Management
DC Funds
Verdad Advisers
Geode Capital Management
Bank of America Corporation
XTX Topco
Jane Street
UBS Group
Vanguard Fiduciary Trust
State Street Corporation

View all funds holding Werewolf Therapeutics